Skip to main content
OpenTrials

Clinical trial condition

Recurrent Head and Neck Cancer

Explore clinical trials studying Recurrent Head and Neck Cancer. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Head and Neck Cancer trial results

Completed

A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes

NCT01620242

Conditions
Disease Attributes, Head and Neck Neoplasms, Metastatic Head and Neck Cancer, +6 more
Locations
  • Centre Oscar Lambret Lille, France
  • Centre Léon Berard Lyon, France
  • Centre Antoine Lacassagne Nice, France
  • Institut Curie Paris, France
View Trial Details
Completed

Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer

NCT02422979

Conditions
Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, +1 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Centura Health Research Center Denver, Colorado, United States
  • Rush University Cancer Center Chicago, Illinois, United States
  • Virginia Piper Cancer Institute, part of Allina Health System Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT06790966

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California, Orange Orange, California, United States
  • Yale University New Haven, Connecticut, United States
View all 28 locations
View Trial Details

Related conditions